Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B ...

Daryl Pritchard, PhD, discusses the challenges to implementing biomarker testing that would advance precision medicine and ...

Foundation Medicine, Inc., a global precision medicine company, today announced an expansion to its collaboration with Bristol Myers Squibb (NYSE: BMY) to develop FoundationOne®CDx as a ...

Delivering this ambition will require collaboration across the cancer ecosystem. Keep Up With Cancer (KUWC), as the ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...

Foundation Medicine has a big IDEA—Improving Diagnostics Education and Awareness—and, now, it's handing out a new grant attached to the program. Specifically, the Boston-based precision medicine ...

A recent study from Baylor College of Medicine and Texas Children’s Hospital has identified a specific neural activity pattern as a novel biomarker to accurately predict and monitor the clinical ...

“Fasting insulin is one of the most crucial — and most overlooked — biomarkers in medicine because it reveals how hard your ...

A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...

According to a latest market analysis by Future Market Insights, the global lung cancer therapeutics market is witnessing strong and s ...

Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid ...

Suggested Citation: "Appendix B: Coding: Payment Infrastructure for Biomarker Tests for Molecularly Targeted Therapies." National Academies of Sciences, Engineering, and Medicine. 2016. Biomarker ...